Guest View
User: Pass: | become a member
Archive for the ‘Immediately available to public’ Category

The Secret Playbook of Internet Trolls

Courtesy of ZeroHedge. View original post here.

Submitted by George Washington.

Pleased to meet you
Hope you guess my name
What’s confusing you
Is the nature of my game

- The Rolling Stones

The reason that Internet trolls are effective is that people still don’t understand their game.

There are 15 commonly-used trolling tactics to disrupt, misdirect and control internet discussions.

As one interesting example, trolls start flame wars because – according to two professors – swearing and name-calling shut down our ability to think and focus.

And trolls will often spew divisive attacks so that people argue against each other, instead of bad actions and policies of the powers-that-be.   For example, trolls will:

Start a religious war whenever possible using stereotypes like “all Jews are selfish”, “all Christians are crazy” or “all Muslims are terrorists”.

Yesterday, the alternative news site Common Dreams caught a troll using scores of different user names to spew anti-Semitic bile. (Common Dreams discovered that the same troll was behind the multiple user names by tracking their IP addresses. And the troll confessed to Common Dreams.)

The troll is a “a Jewish Harvard graduate in his thirties who was irritated by the website’s discussion of issues involving Israel”.

He posted anti-Semitic diatribes – such as Hitler should have finished the job and killed all Jews – using one alias.  Then – a couple of minutes later – he’d post an attack on the first poster using a different alias, claiming that criticism of Israel is the same thing as anti-Semitism.  (Note: Holocaust survivors and Israeli ministers say it’s not.)

Why would a Jew post vile anti-Semitic comments?  Because normal people are offended by – and don’t want to be associated with – pure, naked anti-Semitism, and so they will avoid such discussions.  If the discussion was originally criticizing a specific aspect of Israeli policy, the discussion will break down, and the actual point regarding policy will be lost.

Similarly, anti-Semitic posts weaken websites by making them seem less reputable. Indeed, Common Dreams says that the troll’s anti-Semitic comments drove away many of that site’s largest
continue reading





Stocks To Watch For August 12, 2014

Courtesy of Benzinga.

Related TW
Bank Of America Sees 4Q Beat And Exchange Trends Boost Shares For Towers Watson & Co.
UPDATE: Towers Watson FQ4 Profit Beats Estimates

Related RAX
CNBC's Stock Pops & Drops From August 19
Benzinga's M&A Chatter for Monday August 18, 2014
IBM's (Not So) Secret Weapon: Hybrid Cloud Computing (Fox Business)

Some of the stocks that may grab investor focus today are:

Wall Street expects Towers Watson & Co (NYSE: TW) to report its Q4 earnings at $1.25 per share on revenue of $850.80 million. Towers Watson shares climbed 1.65% to close at $104.27 yesterday.

Rackspace Hosting (NYSE: RAX) reported better-than-expected second-quarter revenue and posted flat earnings in line with analysts’ estimates. The company also forecast Q3 revenue above expectations. Rackspace shares fell 1.47% to $30.85 in the after-hours trading session.

Analysts are expecting Fossil Group (NASDAQ: FOSL) to have earned $0.96 per share on revenue of $770.66 million in the second quarter. Fossil Group shares declined 1.11% to close at $103.21 yesterday.

JPMorgan Chase & Co (NYSE: JPM) agreed to sell approximately 50% of its investment in buyout arm One Equity Partners to Lexington Partners. J.P. Morgan shares declined 0.04% to close at $56.32 yesterday.

Analysts expect Valspar (NYSE: VAL) to report its Q3 earnings at $1.16 per share on revenue of $1.19 billion. Valspar shares rose 0.89% to close at $77.89 yesterday.

Ligand Pharmaceuticals (NASDAQ: LGND) announced a $225 million offering of convertible senior notes and also announced a $200 million share repurchase program. Ligand Pharma shares gained 4.19% to close at $53.65 yesterday.

Flowers Foods (NYSE: FLO) is projected to report its Q2 earnings at $0.24 per share on revenue of $940.83 million. Flowers Foods shares gained 0.35% to close at $20.01 yesterday.

Posted-In: Earnings News Guidance Offerings Buybacks M&A Pre-Market Outlook Markets





Buffett Issues Statement Related to Consent of Final Judgment

Courtesy of Benzinga.

Related BRK-A
Markets Close The Week On Negative Note As Ukraine Worries Mount
Warren Buffett Reveals Quarterly Portfolio Changes As Berkshire Hathaway Shares Hit $200K

Related BRK-B
How To Invest Like A Billionaire Using ETFs
Stocks To Watch For August 4, 2014

“As has been reported today, Berkshire Hathaway Inc. consented to a Final
Judgment whereby we agreed to pay a civil penalty of $896,000 for failure to
comply with the premerger reporting and waiting requirements of the Hart-Scott
Rodino Act. We made a mistake when we overlooked the filing requirement.
Berkshire had owned convertible notes of USG since 2008 and was effectively
forced to convert the notes when they were called for redemption by USG in
December 2013. This event triggered a filing requirement for Berkshire and we
were late in realizing that fact.”

Posted-In: News Hedge Funds Legal Press Releases General





UPDATE: United Continental Q2 Profit Beats Expectations, Shares Surge

Courtesy of Benzinga.

Related UAL
What is Your Stock's Earnings Yield? – Screen of the Week
4 Analysts Agree: Airliner Alpha Potentially Facing A Layover
Uber Opens Systems to Some Partners (Fox Business)

United Continental Holdings (NYSE: UAL) reported a 68% rise in its second-quarter profit.

The Chicago, Illinois-based company posted a quarterly profit of $789 million, or $2.01 per share, versus a year-ago profit of $469 million, or $1.21 per share. Excluding special items, it earned $2.34 per share, versus $1.57 per share.

Its revenue climbed 3.3% to $10.33 billion. However, analysts were projecting earnings of $2.16 per share on revenue of $10.31 billion.

United Continental’s passenger traffic rose 0.6%, while capacity declined 0.1%. The percentage of seats filled rose to 85.3% versus 84.9%, while passenger revenue per available seat mile surged 3.7%.

United Continental announced its plans to launch a $1 billion share repurchase program. It also generated $1.5 billion of operating cash flow in the quarter.

Jeff Smisek, UAL’s chairman, president and chief executive officer said, “I am encouraged by the solid progress we made in the second quarter. Our team is focused on improving our operations and service and on continuing to improve year-over-year revenue performance and cost control.”

United Continental shares gained 5.35% to $48.46 in pre-market trading.

Posted-In: profitEarnings News Buybacks





Vora Fund Takes 16% Stake In Town Sports; Pushes Sale

Courtesy of Benzinga.

Related CLUB
Worst Performing Industries For August 4, 2014
Morning Market Losers

Town Sports International (NASDAQ: CLUB) trended up slightly Thursday after a hedge fund disclosed a 16 percent stake and said it would push the company to explore alternatives including a possible sale.

Town Sports, which runs a string of exercise clubs, has seen its shares drop more than 30 percent in the past month on declining membership and lowered Street estimates.

The company "could attract a range of financial or strategic buyers" based on its real estate and strong brands, Parag Vora's Vora Capital Management said in a filing Thursday.

Vora, which invests in leisure companies, also called on Town Sport to spend $67.1 million on a special dividend or share buyback while cutting overhead and limiting capital spending.

The hedge fund assembled its stake between July 24 and August 13 at prices ranging from $4.04 a share to $6.56.

Town Sports traded recently at $4.33, up 1.1 percent.

Posted-In: Vora Capital ManagementNews Asset Sales M&A





Benzinga’s M&A Chatter for Tuesday August 19, 2014

Courtesy of Benzinga.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday August 19, 2014:

GigOptix Proposes to Acquire GSI Technology for $6.50/Share in Cash, Stock Deal

The Offer:
GigOptix (NYSE MKT: GIG) announced Tuesday that it is proposing to acquire all of the outstanding shares of GSI Technology (NASDAQ: GSIT) for $6.50 per share, consisting of $2.00 per share in cash, plus GigOptix common stock worth $1.33 based upon the volume-weighted average price of GigOptix’s common stock for the three trading days ending one day prior to the closing of the combination and a special dividend of $3.17 per share in cash payable by GSI Technology.

GSI Technology acknowledged the unsolicited, non-binding and conditional proposal from GigOptix, and said its Board of Directors will promptly and carefully review and consider the proposal, respond to it and advise its stockholders of the Board’s response.

GSI Technology closed at $5.41 Tuesday, a gain of 9.55%. GigOptix shares rose $0.01, to close at $1.34.

Allergan Could Acquire Salix for as Much as $190/Share

The Rumor:Shares of Salix Pharmaceuticals (NASDAQ: SLXP) rose sharply Tuesday, on a report from WSJ that Allergan (NYSE: AGN) could acquire the Raleigh, NC drug company for as much as $190 per share or $10 billion, according to sources. The rumored move is being seen as an attempt to make it more difficult for Valeant Pharmaceuticals (NYSE: VRX) to acquire Allergan.

Shares of Jazz Pharmaceuticals rose almost 3% for the day, on reports it too could be a potential takeover target.

Allergan declined comment on the rumor. Salix did not respond to a request for a comment.

Salix Pharmaceuticals closed Tuesday at $160.80, a gain of 15.5%, while Allergan closed at $161.82, a gain of 4%. Shares of Valeant closed at $113.72 a gain of 3.5%.

Report Family Dollar Likely to Reject Dollar General Bid

The Rumor:
CNBC’s David Faber reported Tuesday that Family Dollar’s (NYSE: FDO) Board of Directors is likely to meet this week to discuss the bid…
continue reading





Chipotle Opens Up; Analyst Says Street Comp View Too Low

Courtesy of Benzinga.

Related CMG
Fast Money Traders Share Their Opinions On El Pollo LoCo
Analysts Mostly Agree on El Pollo Loco's Growth Potential, But Disagree On Valuation
Here's How McDonald's Can Get its Mojo Back (Fox Business)

Chipotle Mexican Grill (NYSE: CMG) opened sharply higher Thursday after Cleveland Research said it expects restaurant chain same-store sales growth to accelerate in the wake of menu price hikes.

Cleveland's Steve Gojak believes the high-flying restaurant chain's comparable sales are accelerating from the second quarter on traffic growth and recent price increases.

Gojack reiterated a Buy rating and said Street estimates of same-store sales growth for the third quarter and full year are too low.

Chipotle posted second-quarter same-store sales growth of 17.3 while revenue grew 28 percent to $1.05 billion.

Chipotle, up 30 percent year to date, opened Thursday at $692.92, up more than two percent.

Posted-In: Analyst Color News Guidance Reiteration Analyst Ratings





Tyson To Sell Chicken Operations In Mexico, Brazil To JBS SA For $575 Million

Courtesy of Benzinga.

Related TYN
From Earlier: Tortoise North American Energy Corp Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update
Bank of America Initiates Tortoise North America Energy at Buy

Tyson Foods (NYSE: TSN) signed a definitive agreement Monday to sell its poultry operations in Mexico and Brazil for $575 million in cash to JBS SA (OTC: JBSAY).

Tyson traded recently at $41.31, up 4.4 percent.

Tyson expects the deal to close by the end of 2014, subject to regulatory approval.

Proceeds will pay down debt from Tyson's $7.7 billion acquisition of Hillshire Brands, agreed to earlier this month.

The Mexican business will be acquired through Pilgrim's Pride, whose majority owner is JBS, and which earlier this month lost a bidding war with Tyson to acquire Hillshire Brands.

The Brazilian business is to be acquired through JBS Foods, also a unit of JBS SA.

Tyson, which earlier Monday posted earnings of $0.78 per share, a nickel below forecasts, said the operations to be sold aren't large enough to gain a leading market share in their markets.

Tyson plans to expand its poultry operations in Asia, which include three plants in China and majority ownership of two poultry plants in India.

Posted-In: Earnings News Asset Sales





CBS Corp. Doubles Authorized Buybacks; Q2 Net Sinks 4%

Courtesy of Benzinga.

Related CBS
Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole
3 Companies That Should Grab Xbox Entertainment Studios
Binge Watching, Sports at Center of Fox Bid for Time Warner (Fox Business)

CBS Corp. (NYSE: CBS) second-quarter net earnings from continuing operations fell nearly four percent and the company doubled its stock buyback authorization to $6 billion.

Adjusted earnings per share beat the Wall Street consensus and increased from a year earlier because of the effects of share repurchases.

Second-quarter revenue fell 5.3 percent compared with the 2013 second quarter, when revenue benefited from benefited from the timing of TV licensing and the semifinals of an NCAA Men’s Basketball Championship.

Entertainment revenue fell 8.4 percent to $1.84 billion from $2.01 billion a year earlier on lower licensing and advertising sales.

Cable Networks revenue was nearly flat at $516 million.

Local Broadcasting revenue dropped 4.7 percent to $665 million from $698 million in the same prior-year period, because of slower advertising sales.

Publishing revenue grew 11 percent to $211 million from $189 million a year earlier, driven by higher print book sales. Digital sales equaled 25 percent of the unit’s total sales.

CBS posted net income from continuing operations of $439 million, or $0.72 cents a share, compared with $472 million or $0.70 cents a share a year earlier. Revenue fell to $3.19 billion from $3.37 billion.

Adjusted income per share was $0.78 cents, up from $0.75 a year earlier. Analysts expected adjusted income of $0.71 cents.

CBS changed hands recently after hours down 2.4 percent at $55.55.

Posted-In: Earnings News Buybacks After-Hours Center





Lannett To Acquire Two Generic Pharmaceutical Products

Courtesy of Benzinga.

Related LCI
Lannett Sinks On Safety, Pricing Worries Over Generic Heart Drug
Dow Posts Triple-Digit Point Gain; S&P 500 And NASDAQ Also Higher As Global Concerns Calm

Lannett Company, Inc. (NYSE: LCI) today announced that it has agreed to purchase ANDAs for Estradiol Tablets, USP, 0.5 mg, 1 mg and 2 mg, and Selegiline Hydrochloride Capsules 5 mg, upon the completion of a successful technical transfer. The company did not disclose the name of the seller nor the financial terms of the transaction.

Lannett expects to launch Estradiol Tablets within the next several months and Selegiline Hydrochloride Capsules sometime thereafter. According to IMS, for the full year 2013 total sales of Estradiol Tablets, USP, 0.5 mg, 1 mg and 2 mg, and Selegiline Hydrochloride Capsules 5 mg at Average Wholesale Price (AWP) were approximately $31.0 million and $8.5 million, respectively. The reference listed drug manufacturer for Estradiol Tablets is Barr Laboratories (now a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd.); Selegiline Hydrochloride Capsules 5 mg is the generic equivalent of Somerset Pharmaceuticals, Inc.’s Eldepryl®.

“We are pleased to add Estradiol Tablets and Selegiline Hydrochloride Capsules to our offering,” said Arthur Bedrosian, president and chief executive officer of Lannett. “The acquisition of these two important

Posted-In: News Legal Press Releases





 

Help One Of Our Own PSW Members

"Hello PSW Members –

This is a non-trading topic, but I wanted to post it during trading hours so as many eyes can see it as possible.  Feel free to contact me directly at jennifersurovy@yahoo.com with any questions.

Last fall there was some discussion on the PSW board regarding setting up a YouCaring donation page for a PSW member, Shadowfax. Since then, we have been looking into ways to help get him additional medical services and to pay down his medical debts.  After following those leads, we are ready to move ahead with the YouCaring site. (Link is posted below.)  Any help you can give will be greatly appreciated; not only to help aid in his medical bill debt, but to also show what a great community this group is.

http://www.youcaring.com/medical-fundraiser/help-get-shadowfax-out-from-the-darkness-of-medical-bills-/126743"

Thank you for you time!

 
 

Zero Hedge

The Secret Playbook of Internet Trolls

Courtesy of ZeroHedge. View original post here.

Submitted by George Washington.

Pleased to meet you
Hope you guess my name
What’s confusing you
Is the nature of my game

- The Rolling Stones

The reason that Internet trolls are effective is that people still don’t understand their game.

There are 15 commonly-used trolling tactics to disrupt, misdirect and control internet discussions....



more from Tyler

Insider Scoop

Point72 Still Under A Cloud As President Plans To Step Down

Courtesy of Benzinga.

Related SPY 3 Reasons To Follow The Big Dog In Natural Resources Fed Issues FOMC Minutes from Jul. 29-30th, 2014 Meeting Dow 17K: A Story of Recovery, Perseverance (Fox Business)

Hedge fund giant Point72 Asset Management said its president, Thomas Conheeney, will step down at the end of 2014 and be succeeded by Douglas Haynes, managing director for human capital at Point72.

Formerly known as SAC Capital Advisors,...



http://www.insidercow.com/ more from Insider

Phil's Favorites

One Paragraph Cuts Through The Hype Of Robots Taking Your Job

One Paragraph Cuts Through The Hype Of Robots Taking Your Job

Courtesy of , Business Insider

Screenshot / YouTube

The official schedule for the Jackson Hole economic conference is up, and there have been several papers posted.

One very interesting paper comes from MIT professor David Autor...



more from Ilene

Chart School

Gasoline Volume Sales, Demographics and our Changing Culture

Courtesy of Doug Short.

The Department of Energy's Energy Information Administration (EIA) data on volume sales is over two months old when it released. The latest numbers, through mid-May, were published today. However, despite the lag, this report offers an interesting perspective on fascinating aspects of the US economy. Gasoline prices and increases in fuel efficiency are important factors, but there are also some significant demographic and cultural dynamics in this data series.

Because the sales data are highly volatile with some obvious seasonality, I've added a 12-month moving average (MA) to give a clearer indication of the long-term trends. The latest 12-month MA is 8.8% below the all-time high set in August 2005, a new interim low.

...



more from Chart School

Option Review

CME Group Put Options Active

Options volume on the provider of futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals and alternative investment products is well above average on Thursday morning, due in large part to a sizable put spread initiated in the 19Sep’14 expiry contracts. Shares in CME Group (Ticker: CME) are up slightly on the day, trading 0.25% higher at $74.34 as of the time of this writing.

The largest trade on CME today appears to be a bear put spread in which roughly 1,500 of the 19Sep’14 74.0 strike puts were purchased at a premium of $1.44 each against the sale of the same number of t...



more from Caitlin

All About Trends

Mid-Day Update

Reminder: David is available to chat with Members, comments are found below each post.

Click here for the full report.




To learn more, sign up for David's free newsletter and receive the free report from All About Trends - "How To Outperform 90% Of Wall Street With Just $500 A Week." Tell David PSW sent you. - Ilene...

more from David

Sabrient

Sector Detector: Bullish investors jockey for position as if the correction is over

Courtesy of Sabrient Systems and Gradient Analytics

As many investors enjoy the final weeks of summer, some optimistic bulls seem to be positioning themselves well ahead of Labor Day in anticipation of a fall rally. Indeed, last week’s action was impressive. After only a mere 4% correction, investors continued to brush off the disturbing violence both at home and abroad, and they took the minor pullback as their next buying opportunity. But was that really all the pullback we’re going to get this year? I doubt it. But I also believe that nothing short of a major Black Swan event can send this market into a deep correction.

In this weekly update, I give my view of the current market environment, offer a technical analysis of the S&P 500 chart, review our weekly fundamentals-based SectorCast rankings of the ten U.S. business sectors, and then ...



more from Sabrient

OpTrader

Swing trading portfolio - week of August 18th, 2014

Reminder: OpTrader is available to chat with Members, comments are found below each post.

 

This post is for all our live virtual trade ideas and daily comments. Please click on "comments" below to follow our live discussion. All of our current  trades are listed in the spreadsheet below, with entry price (1/2 in and All in), and exit prices (1/3 out, 2/3 out, and All out).

We also indicate our stop, which is most of the time the "5 day moving average". All trades, unless indicated, are front-month ATM options. 

Please feel free to participate in the discussion and ask any questions you might have about this virtual portfolio, by clicking on the "comments" link right below.

To learn more about the swing trading virtual portfolio (strategy, performance, FAQ, etc.), please click here ...



more from OpTrader

Stock World Weekly

Stock World Weekly

Newsletter writers are available to chat with Members regarding topics presented in SWW, comments are found below each post.

The Stock World Weekly Newsletter is ready to go! View it here: Stock World Weekly. Just put in your user name and password, or take a free trial. 

 

#120692880 / gettyimages.com ...

more from SWW

Market Shadows

Helen Davis Chaitman Reviews In Bed with Wall Street.

Author Helen Davis Chaitman is a nationally recognized litigator with a diverse trial practice in the areas of lender liability, bankruptcy, bank fraud, RICO, professional malpractice, trusts and estates, and white collar defense. In 1995, Ms. Chaitman was named one of the nation's top ten litigators by the National Law Journal for a jury verdict she obtained in an accountants' malpractice case. Ms. Chaitman is the author of The Law of Lender Liability (Warren, Gorham & Lamont 1990)... Since early 2009, Ms. Chaitman has been an outspoken advocate for investors in Bernard L. Madoff Investment Securities LLC (more here).

Helen Davis Chaitman Reviews In Bed with Wall Street. 

By Helen Davis Chaitman   

I confess: Larry D...



more from Paul

Digital Currencies

BitLicense Part 1 - Can Poorly Thought Out Regulation Drive the US Economy Back into the Dark Ages?

Courtesy of Reggie Middleton.

An Op-Ed piece penned by Veritaseum Chief Contracts Officer, Matt Bogosian

This past weekend (despite American Airlines' best efforts), Reggie and I made it to the Second Annual North American Bitcoin Conference in Chicago. While there were some very creative (and very ambitious) ideas on how to try to realize the disruptive Bitcoin protocol, one of the predominant topics of discussion was New York Superintendent of Financial Services Benjamin Lawsky's proposed Bitcoin regulations (the BitLicense proposal) - percieved by many participants at the event as an apparent ...



more from Bitcoin

Pharmboy

Biotechs & Bubbles

Reminder: Pharmboy is available to chat with Members, comments are found below each post.

Well PSW Subscribers....I am still here, barely.  From my last post a few months ago to now, nothing has changed much, but there are a few bargins out there that as investors, should be put on the watch list (again) and if so desired....buy a small amount.

First, the media is on a tear against biotechs/pharma, ripping companies for their drug prices.  Gilead's HepC drug, Sovaldi, is priced at $84K for the 12-week treatment.  Pundits were screaming bloody murder that it was a total rip off, but when one investigates the other drugs out there, and the consequences of not taking Sovaldi vs. another drug combinations, then things become clearer.  For instance, Olysio (JNJ) is about $66,000 for a 12-week treatment, but is approved for fewer types of patients AND...



more from Pharmboy

Promotions

See Live Demo Of This Google-Like Trade Algorithm

I just wanted to be sure you saw this.  There’s a ‘live’ training webinar this Thursday, March 27th at Noon or 9:00 pm ET.

If GOOGLE, the NSA, and Steve Jobs all got together in a room with the task of building a tremendously accurate trading algorithm… it wouldn’t just be any ordinary system… it’d be the greatest trading algorithm in the world.

Well, I hate to break it to you though… they never got around to building it, but my friends at Market Tamer did.

Follow this link to register for their training webinar where they’ll demonstrate the tested and proven Algorithm powered by the same technological principles that have made GOOGLE the #1 search engine on the planet!

And get this…had you done nothing b...



more from Promotions



FeedTheBull - Top Stock market and Finance Sites



About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>


As Seen On:




About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the site market shadows, archives, more. Contact Ilene to learn about our affiliate and content sharing programs.

Market Shadows >>